Table 3 Changes in clinical characteristics of patients enrolled according to intervention (N = 151) after 24 weeks
Variables | Subgroups | N(%) or Mean (SD) or Median (IQR) | Test | p value | ||
|---|---|---|---|---|---|---|
Conventional Care | iCaPPS© | |||||
Systolic BP (mmHg) | Baseline | 130.0 (120.0,143.5) | 130.0 (120.0,140,0) | z = −0.172 | 0.864 | |
Exit | 131.0 (120.0,150.0) | 130.0 (120.0,140.0) | z = −0.853 | 0.394 | ||
Diastolic BP (mmHg) | Baseline | 76.0 (70.0,82.0) | 80.0 (70.0,85.0) | z = −0.929 | 0.353 | |
Exit | 80.0 (70.0,84.0) | 80.0 (70.0,84.0) | z = −0.280 | 0.780 | ||
Total cholesterol (mmol/L) | Baseline | 4.98 (4.13,5.73) | 4.60 (4.01,5,44) | z = −1.138 | 0.255 | |
Exit | 4.90 (4.19.5.86) | 4.45 (3.90,5.20) | z = −2.067 | 0.039 | ||
LDL-cholesterol (mmol/L) | Baseline | 3.2 ± 1.0 | 2.9 ± 0.9 | t = 1.886, df = 137 | 0.061 | |
Exit | 2.9 (2.2,3.9) | 2.4 (2.0,3.2) | z = −2.557 | 0.010 | ||
Triglyceride (mmol/L) | Baseline | 1.4 (1.1,2.0) | 1.3 (1.0,2.0) | z = −1.683 | 0.092 | |
Exit | 1.5 (1.1,1.9) | 1.4 (1.1,1.7) | z = −1.037 | 0.300 | ||
HDL-cholesterol (mmol/L) | Baseline | 1.3 (1.0,4.7) | 1.2 (1.0,1.4) | z = −2.038 | 0.021 | |
Exit | 1.1 (1.0,1.4) | 1.1 (1.0,1.4) | z = 0.779 | 0.436 | ||
HbA1c (%) | Baseline | 7.2 (6.4,11.2) | 6.7 (6.0,7.9) | z = −2.445 | 0.014 | |
Exit | 7.1 (6.2,10.4) | 6.7 (6.0,7.8) | z = −1.927 | 0.054 | ||
Functional status, modified Barthel Index (mBI) scores | Baseline | 90 (75,100) | 95 (75,100) | z = −0.430 | 0.667 | |
Exit | 82.1 (75,100) | 95 (80,100) | z = −0.400 | 0.689 | ||
Depression screen, PHQ9 scores | Baseline | ≥10 | 6 (9.2) | 6 (7.0) | Fisher’s exact | 0.793 |
< 10 | 59 (90.8) | 80 (93.0) | ||||
Exit | ≥10 | 1 (1.2) | 6 (7.0) | Fisher’s exact | 0.240 | |
< 10 | 85 (98.8) | 80 (93.0) | ||||